Jones S - Search Results

1

Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation.

Ponsford MJ, Gkatzionis A, Walker VM, Grant AJ, Wootton RE, Moore LSP, Fatumo S, Mason AM, Zuber V, Willer C, Rasheed H, Brumpton B, Hveem K, Kristian Damås J, Davies N, Åsvold BO, Solligård E, Jones S, Burgess S, Rogne T, Gill D. Ponsford MJ, et al. Among authors: jones s. Circulation. 2020 Nov 3;142(18):1791-1793. doi: 10.1161/CIRCULATIONAHA.120.050753. Epub 2020 Sep 23. Circulation. 2020. PMID: 32966752 Free PMC article. No abstract available.

2

Association of Genetic Risk for Rheumatoid Arthritis With Cognitive and Psychiatric Phenotypes Across Childhood and Adolescence.

Jones HJ, Hubbard L, Mitchell RE, Jones SA, Williams NM, Zammit S, Hall J. Jones HJ, et al. Among authors: jones sa. JAMA Netw Open. 2019 Jun 5;2(6):e196118. doi: 10.1001/jamanetworkopen.2019.6118. JAMA Netw Open. 2019. PMID: 31225891 Free PMC article.

3

Is IL-6 a key cytokine target for therapy in COVID-19?

Jones SA, Hunter CA. Jones SA, et al. Nat Rev Immunol. 2021 Jun;21(6):337-339. doi: 10.1038/s41577-021-00553-8. Nat Rev Immunol. 2021. PMID: 33850327 Free PMC article. Review.

4

IL-27: a double agent in the IL-6 family.

Jones GW, Hill DG, Cardus A, Jones SA. Jones GW, et al. Among authors: jones sa. Clin Exp Immunol. 2018 Jul;193(1):37-46. doi: 10.1111/cei.13116. Epub 2018 Mar 9. Clin Exp Immunol. 2018. PMID: 29437229 Free PMC article. Review.

5

Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology.

Lauder SN, Jones E, Smart K, Bloom A, Williams AS, Hindley JP, Ondondo B, Taylor PR, Clement M, Fielding C, Godkin AJ, Jones SA, Gallimore AM. Lauder SN, et al. Among authors: jones e, jones sa. Eur J Immunol. 2013 Oct;43(10):2613-25. doi: 10.1002/eji.201243018. Epub 2013 Aug 12. Eur J Immunol. 2013. PMID: 23857287 Free PMC article.

6

The biology behind interleukin-6 targeted interventions.

Liu X, Jones GW, Choy EH, Jones SA. Liu X, et al. Curr Opin Rheumatol. 2016 Mar;28(2):152-60. doi: 10.1097/BOR.0000000000000255. Curr Opin Rheumatol. 2016. PMID: 26751841 Review.

7

Making sense of IL-6 signalling cues in pathophysiology.

Millrine D, Jenkins RH, Hughes STO, Jones SA. Millrine D, et al. FEBS Lett. 2022 Mar;596(5):567-588. doi: 10.1002/1873-3468.14201. Epub 2021 Oct 15. FEBS Lett. 2022. PMID: 34618359 Free PMC article. Review.

8

Unravelling the broader complexity of IL-6 involvement in health and disease.

Jenkins RH, Hughes STO, Figueras AC, Jones SA. Jenkins RH, et al. Cytokine. 2021 Dec;148:155684. doi: 10.1016/j.cyto.2021.155684. Epub 2021 Aug 16. Cytokine. 2021. PMID: 34411990 Review.

9

Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A.

Jones GW, Greenhill CJ, Williams JO, Nowell MA, Williams AS, Jenkins BJ, Jones SA. Jones GW, et al. Among authors: jones sa. Ann Rheum Dis. 2013 Oct;72(10):1738-42. doi: 10.1136/annrheumdis-2013-203771. Epub 2013 Jul 26. Ann Rheum Dis. 2013. PMID: 23894061 Free PMC article.

10

Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues.

Jones GW, Jones SA. Jones GW, et al. Immunology. 2016 Feb;147(2):141-51. doi: 10.1111/imm.12554. Epub 2015 Dec 10. Immunology. 2016. PMID: 26551738 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,542 results

Search Page